- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Parkinson disease
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Levodopa with carbidopa – November 2019
Levodopa with Carbidopa: Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL; Duodopa®
Last updated
6 March 2020